Literature DB >> 24221454

[Pneumococcus vaccination in immunosuppressed patients: current recommendations].

A Krause1, K Krüger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24221454     DOI： 10.1007/s00393-013-1257-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  25 in total

1.  Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate.

Authors:  Elizabeth Coulson; Vadivelu Saravanan; Jennifer Hamilton; Kin Long So; Kin So Long; Lynn Morgan; Carol Heycock; Martin Rynne; Clive Kelly
Journal:  Ann Rheum Dis       Date:  2011-04-22       Impact factor: 19.103

2.  [S3-guideline on ambulant acquired pneumonia and deep airway infections].

Authors:  G Höffken; J Lorenz; W Kern; T Welte; T Bauer; K Dalhoff; E Dietrich; S Ewig; P Gastmeier; B Grabein; E Halle; M Kolditz; R Marre; H Sitter
Journal:  Pneumologie       Date:  2005-09

3.  The risk of hospitalized infection in patients with rheumatoid arthritis.

Authors:  Allison L Smitten; Hyon K Choi; Marc C Hochberg; Samy Suissa; Teresa A Simon; Marcia A Testa; K Arnold Chan
Journal:  J Rheumatol       Date:  2008-02-01       Impact factor: 4.666

4.  [Vaccination recommendations of the Commission for Pharmacotherapy of the German Society of Rheumatology].

Authors:  K Warnatz; S Goldacker; A M Gause
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

5.  Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.

Authors:  Maria Rehnberg; Mikael Brisslert; Sylvie Amu; Kiandoht Zendjanchi; Gunilla Håwi; Maria I Bokarewa
Journal:  Arthritis Res Ther       Date:  2010-06-08       Impact factor: 5.156

6.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Authors:  Tamara Pilishvili; Catherine Lexau; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Arthur Reingold; Ann Thomas; William Schaffner; Allen S Craig; Philip J Smith; Bernard W Beall; Cynthia G Whitney; Matthew R Moore
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

7.  Increasing pneumococcal vaccination for immunosuppressed patients: a cluster quality improvement trial.

Authors:  Sonali P Desai; Bing Lu; Lara E Szent-Gyorgyi; Anna A Bogdanova; Alexander Turchin; Michael Weinblatt; Jonathan Coblyn; Jeffrey O Greenberg; Allen Kachalia; Daniel H Solomon
Journal:  Arthritis Rheum       Date:  2013-01

8.  Pneumococcal conjugate vaccine for adults: a new paradigm.

Authors:  Peter R Paradiso
Journal:  Clin Infect Dis       Date:  2012-04-11       Impact factor: 9.079

9.  New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality.

Authors:  S Ewig; N Birkner; R Strauss; E Schaefer; J Pauletzki; H Bischoff; P Schraeder; T Welte; G Hoeffken
Journal:  Thorax       Date:  2009-05-18       Impact factor: 9.139

10.  Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy.

Authors:  Shunsuke Mori; Yukitaka Ueki; Yukihiro Akeda; Naoyuki Hirakata; Motohiro Oribe; Yoshiki Shiohira; Toshihiko Hidaka; Kazunori Oishi
Journal:  Ann Rheum Dis       Date:  2013-01-23       Impact factor: 19.103
View more
  1 in total

1.  [Prophylaxis and treatment of infections in elderly patients with rheumatism].

Authors:  C Kneitz; A Strangfeld; K Krüger
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.